STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIP
  4. [Form 4] Arteris, Inc. Insider Trading Activity

Director at Arteris (AIP) receives 4,703 RSUs equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Munce Claudia F. reported acquisition or exercise transactions in this Form 4 filing.

Arteris, Inc. director Claudia F. Munce received an equity grant of 4,703 restricted stock units (RSUs), each representing one share of common stock. These RSUs vest in full on the earlier of the first anniversary of the June 2, 2026 grant date or immediately before the next annual stockholder meeting, if she continues serving on the board. The grant value was based on the average trading price of $31.89 over the period from April 21, 2026 through June 2, 2026. Following this award, she holds a total of 106,414 common shares directly, and has elected to defer receipt of the shares underlying this RSU grant.

Positive

  • None.

Negative

  • None.
Insider Munce Claudia F.
Role null
Type Security Shares Price Value
Grant/Award Common Stock 4,703 $0.00 --
Holdings After Transaction: Common Stock — 106,414 shares (Direct, null)
Footnotes (1)
  1. Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89. The Reporting Person elected to defer the receipt of shares.
RSUs granted 4,703 RSUs Equity award to director on June 2, 2026
Reference share price $31.89 Average trading price April 21, 2026–June 2, 2026
Shares per RSU 1 share per RSU Each RSU converts to one common share
Total shares after grant 106,414 shares Direct holdings following the RSU award
Vesting trigger Earlier of 1-year or next annual meeting Subject to continued board service
restricted stock units ("RSUs") financial
"Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vest in full financial
"The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date"
annual meeting of the Issuer's stockholders financial
"immediately before the annual meeting of the Issuer's stockholders following the grant date"
deferr the receipt of shares financial
"The Reporting Person elected to defer the receipt of shares."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Munce Claudia F.
(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300
(Street)
CAMPBELL CALIFORNIA 95008
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026A4,703(1)(2)A$0.00106,414D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89.
2. The Reporting Person elected to defer the receipt of shares.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Munce Claudia F.06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Arteris (AIP) director Claudia Munce report in this Form 4?

Claudia F. Munce reported receiving 4,703 restricted stock units, each representing one Arteris common share. The award is part of her director compensation and increases her direct holdings to 106,414 shares following the transaction.

How many Arteris (AIP) RSUs were granted to Claudia Munce and at what reference price?

She was granted 4,703 restricted stock units. The grant was valued using the average Arteris common stock trading price of $31.89 for the period from April 21, 2026 through June 2, 2026, as specified in the footnotes.

When do Claudia Munce’s Arteris (AIP) RSUs vest?

The 4,703 RSUs vest in full on the earlier of the first anniversary of the June 2, 2026 grant date or immediately before the next annual stockholder meeting, provided she continues serving on Arteris’ board through that vesting date.

Did Claudia Munce pay cash for the Arteris (AIP) RSU grant?

No cash was paid for this award. The Form 4 shows a transaction price of $0.00 per share, indicating it is a compensation-related grant rather than an open-market purchase, with value referenced to Arteris’ $31.89 average trading price.

What is Claudia Munce’s Arteris (AIP) ownership after this RSU grant?

After the grant, she directly holds 106,414 Arteris common shares, including the 4,703 RSUs. Each RSU represents a contingent right to receive one share, subject to vesting and her continued board service through the specified vesting date.

Did Claudia Munce defer receipt of her Arteris (AIP) RSU shares?

Yes. A footnote states that the reporting person elected to defer the receipt of shares. This means the actual delivery of common stock underlying the 4,703 RSUs will occur later under Arteris’ applicable deferral provisions.